Preoperative albumin-bilirubin score predicts short-term outcomes and long-term prognosis in colorectal cancer patients undergoing radical surgery

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

WORD

HTML

Figures (1-3)

Tables (1-5)

Sum=86

Publishing Process of This Article

Item

Count

Browse

Download

Sum=27

Jul 27, 2024 (publication date) through Jul 27, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Surg. Jul 27, 2024; 16(7): 2096-2105
Published online Jul 27, 2024. doi: 10.4240/wjgs.v16.i7.2096

Table 5 Previous studies reporting the albumin-bilirubin score of colorectal cancer patients

Ref.	Year	Country	Sample size	High ALBI, n (%)	Patients	Outcomes
Zhu et al[26]	2020	China	284	165 (58.1)	CRC	ALBI score was an independent indicator for postoperative complications and OS after radical surgery
Koh et al[27]	2022	South Korea	1015	173 (17.0)	CRC	ALBI score was an independent risk factor for OS in patients after radical CRC patients
Abdel-Rahman[28]	2019	Canada	1434	648 (45.2)	mCRC	ALBI score was an independent risk factor for OS and progression-free survival in CRC patients with liver metastasis after chemotherapy
Watanabe et al[29]	2021	Japan	60	28 (46.7)	CRC	High-ALBI group had shorter OS, and was correlated with shorter time to treatment failure and liver dysfunction in CRC patients treated with regorafenib

CRC: Colorectal cancer; mCRC: Metastatic colorectal cancer; ALBI: Albumin-bilirubin; OS: Overall survival.

Citation: Diao YH, Shu XP, Tan C, Wang LJ, Cheng Y. Preoperative albumin-bilirubin score predicts short-term outcomes and long-term prognosis in colorectal cancer patients undergoing radical surgery. World J Gastrointest Surg 2024; 16(7): 2096-2105
URL: https://www.wjgnet.com/1948-9366/full/v16/i7/2096.htm
DOI: https://dx.doi.org/10.4240/wjgs.v16.i7.2096